Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of FERMENTA BIOTECH. For more details, see the FERMENTA BIOTECH quarterly results and FERMENTA BIOTECH share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -2.9 |
No. of shares | m | 29.43 |
1 Week | % | 2.0 |
1 Month | % | 18.3 |
1 Year | % | 24.0 |
52 week H/L | Rs | 214.0/132.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
FERMENTA BIOTECH EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 4,095 | 1,011 | 442 | 370 | 280 | |
Low | Rs | 691 | 151 | 218 | 204 | 103 | |
Sales per share (Unadj.) | Rs | 441.3 | 101.5 | 130.8 | 138.1 | 121.3 | |
Earnings per share (Unadj.) | Rs | 128.6 | 20.6 | 14.7 | 5.2 | -18.6 | |
Diluted earnings per share | Rs | 40.1 | 20.2 | 14.5 | 5.1 | -18.2 | |
Cash flow per share (Unadj.) | Rs | 141.5 | 25.8 | 21.8 | 14.1 | -8.8 | |
Dividends per share (Unadj.) | Rs | 1.25 | 5.00 | 2.50 | 1.25 | 1.25 | |
Adj. dividends per share | Rs | 0.39 | 4.90 | 2.45 | 1.23 | 1.23 | |
Avg Dividend yield | % | 0.1 | 0.9 | 0.8 | 0.4 | 0.7 | |
Book value per share (Unadj.) | Rs | 272.4 | 105.2 | 120.8 | 123.9 | 104.4 | |
Adj. book value per share | Rs | 84.9 | 103.1 | 118.4 | 121.5 | 102.4 | |
Shares outstanding (eoy) | m | 9.17 | 28.85 | 28.85 | 28.85 | 28.86 | |
Price / Sales ratio | x | 5.4 | 5.7 | 2.5 | 2.1 | 1.6 | |
Avg P/E ratio | x | 18.6 | 28.2 | 22.4 | 55.0 | -10.3 | |
P/CF ratio (eoy) | x | 16.9 | 22.5 | 15.1 | 20.4 | -21.9 | |
Price / Book Value ratio | x | 8.8 | 5.5 | 2.7 | 2.3 | 1.8 | |
Dividend payout | % | 1.0 | 24.2 | 17.0 | 23.9 | -6.7 | |
Avg Mkt Cap | Rs m | 21,951 | 16,760 | 9,520 | 8,284 | 5,531 | |
Total wages/salary | Rs m | 532 | 500 | 582 | 630 | 579 |
FERMENTA BIOTECH INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,047 | 2,929 | 3,773 | 3,985 | 3,499 | |
Other income | Rs m | 265 | 142 | 84 | 83 | 77 | |
Total revenues | Rs m | 4,312 | 3,072 | 3,857 | 4,068 | 3,576 | |
Gross profit | Rs m | 1,353 | 643 | 826 | 622 | -99 | |
Depreciation | Rs m | 119 | 150 | 203 | 256 | 282 | |
Interest | Rs m | 212 | 201 | 190 | 180 | 214 | |
Profit before tax | Rs m | 1,287 | 434 | 516 | 269 | -519 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 108 | -161 | 91 | 119 | 17 | |
Profit after tax | Rs m | 1,179 | 595 | 425 | 151 | -536 | |
Gross profit margin | % | 33.4 | 22.0 | 21.9 | 15.6 | -2.8 | |
Effective tax rate | % | 8.4 | -37.1 | 17.6 | 44.1 | -3.2 | |
Net profit margin | % | 29.1 | 20.3 | 11.3 | 3.8 | -15.3 |
FERMENTA BIOTECH BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,956 | 2,840 | 3,304 | 3,347 | 2,737 | |
Current liabilities | Rs m | 1,560 | 1,946 | 2,301 | 2,278 | 2,294 | |
Net working cap to sales | % | 34.5 | 30.5 | 26.6 | 26.8 | 12.7 | |
Current ratio | x | 1.9 | 1.5 | 1.4 | 1.5 | 1.2 | |
Inventory Days | Days | 92 | 114 | 69 | 78 | 58 | |
Debtors Days | Days | 591 | 869 | 658 | 798 | 434 | |
Net fixed assets | Rs m | 2,261 | 2,916 | 3,914 | 4,186 | 3,650 | |
Share capital | Rs m | 46 | 144 | 144 | 144 | 144 | |
"Free" reserves | Rs m | 2,452 | 2,889 | 3,342 | 3,430 | 2,870 | |
Net worth | Rs m | 2,498 | 3,034 | 3,486 | 3,574 | 3,014 | |
Long term debt | Rs m | 1,352 | 1,018 | 1,104 | 1,147 | 836 | |
Total assets | Rs m | 5,319 | 5,756 | 7,218 | 7,533 | 6,387 | |
Interest coverage | x | 7.1 | 3.2 | 3.7 | 2.5 | -1.4 | |
Debt to equity ratio | x | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | |
Sales to assets ratio | x | 0.8 | 0.5 | 0.5 | 0.5 | 0.5 | |
Return on assets | % | 26.2 | 13.8 | 8.5 | 4.4 | -5.0 | |
Return on equity | % | 47.2 | 19.6 | 12.2 | 4.2 | -17.8 | |
Return on capital | % | 38.9 | 15.7 | 15.4 | 9.5 | -7.9 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 1,977 | 2,551 | 2,287 | 1,597 | |
Fx outflow | Rs m | 0 | 935 | 1,035 | 779 | 608 | |
Net fx | Rs m | 0 | 1,041 | 1,516 | 1,508 | 989 |
FERMENTA BIOTECH CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 903 | 345 | 626 | 434 | 1,167 | |
From Investments | Rs m | -966 | -437 | -416 | -260 | -563 | |
From Financial Activity | Rs m | 122 | -474 | -11 | -216 | -408 | |
Net Cashflow | Rs m | 60 | -566 | 205 | -42 | 196 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Pradeep M Chandan | COMP SEC: Srikant N Sharma | YEAR OF INC: 1951 | BSE CODE: 506414 | FV (Rs): 5 | DIV YIELD (%): 0.7 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare FERMENTA BIOTECH With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.